Aurora Spine revealed that its DEXA-C system has now been successfully used in over 1,500 cervical spine surgeries in the U.S.

According to the company, its DEXA tech is the world’s first spinal implant platform engineered to match a patient’s bone density across the BMD continuum, including normal, osteopenic, and osteoporotic bone.

Each implant is designed with open, porous architecture that promotes osseointegration and vascularization. It also mimics cancellous bone structure to create a similar modulus of elasticity and better biomechanical compatibility.

The company expects to launch DEXA-L in Q4 of this year. DEXA-L is a standalone anterior lumbar interbody fusion (ALIF) system and is also designed to address spinal fusion in various bone densities—particularly those with osteoporosis.

RELATED: Aurora Spine Nabs 2nd U.S. Patent for DEXA Patient-Matched Implant Tech

DEXA technology was invented to tackle the reduced performance of spinal implants in patients with low bone density, where traditional designs might lack adequate bone-implant contact and fail to achieve long-term fixation.

“DEXA-C provides surgeons with the first tool that truly puts bone quality at the center of implant selection,” said Trent Northcutt, president and CEO of Aurora Spine. “With over 1,500 successful surgeries behind us, the data is clear: this technology improves outcomes. And now, we’re ready to take it even further as we build out our sales efforts for this platform technology and prepare launch for our second DEXA Technology-enabled product the DEXA-L, which will be rolled out later this year.”

Earlier this month, the company celebrated that its SiLO sacroiliac (SI) joint fusion system was successfully utilized in more than 2,500 procedures in the U.S.